SmileDirectClub Shares Outstanding 2018-2023 | SDCCQ
SmileDirectClub shares outstanding from 2018 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
SmileDirectClub Annual Shares Outstanding (Millions of Shares) |
2022 |
390 |
2021 |
388 |
2020 |
385 |
2019 |
382 |
2018 |
0 |
2017 |
0 |
SmileDirectClub Quarterly Shares Outstanding (Millions of Shares) |
2023-06-30 |
401 |
2023-03-31 |
399 |
2022-12-31 |
390 |
2022-09-30 |
390 |
2022-06-30 |
390 |
2022-03-31 |
389 |
2021-12-31 |
388 |
2021-09-30 |
388 |
2021-06-30 |
388 |
2021-03-31 |
387 |
2020-12-31 |
385 |
2020-09-30 |
386 |
2020-06-30 |
385 |
2020-03-31 |
384 |
2019-12-31 |
382 |
2019-09-30 |
379 |
2019-06-30 |
|
2019-03-31 |
|
2018-12-31 |
|
2018-09-30 |
0 |
2017-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$0.000B |
$0.471B |
SmileDirectClub, Inc. is an oral care company and claims to be the creator of the first MedTech platform for teeth straightening. By its new teledentistry technology and vertically integrated model, it's playing a key role in the oral care industry. It offers professional-level service and high-quality doctor's reviewed clear aligners at a low cost. It has developed a number of proprietary processes and technologies, like complex software solutions, laser, destructive & white light scanning techniques, stereolithography, 3D printing, and thermoforming. The manufacturing is performed by Access Dental Lab, LLC, its wholly owned subsidiary. Its proprietary teledentistry platform, SmileCheck enables marketing to aligner manufacturing, fulfillment, treatment by a member's doctor, and monitoring through completion of their treatment. Its financing program, SmilePay is a convenient monthly payment plan. It accepts insurance and is in-network with UnitedHealthcare, Aetna, Anthem, Cigna, Guardian, HUMANA and MetLife.
|